- EVIO is a leading provider of cannabis analysis and testing in the U.S.
- Company on track to reach 18 labs by year-end 2018
- Company is guided by strong team of industry and business experts
Operating in one the hottest industries in the marketplace right now, EVIO, Inc. (OTCQB: EVIO) is a life sciences company leading the charge in cannabis analysis and testing. The company currently operates several laboratories throughout the United States—with many more on the horizon—and is a leading provider of accredited cannabis testing, delivering top-quality analytical and consulting services for agricultural and biomedical industries, as well as performing product research. Through its EVIO Labs division, the company offers state-mandated ancillary services to help ensure the quality and safety of the U.S. cannabis supply.
EVIO is on track to open additional labs that will raise its total count to 18 by the end of 2018, and the company has reached this prime position under the guidance of a strong management team composed of business leaders and industry experts.
At the company’s helm are William Waldrop, MBA, and Lori Glauser, BSME, MS/MBA, who cofounded parent company Signal Bay, Inc. and have guided EVIO from its foundations as a startup advisory firm in 2014 to its current nationwide presence.
Serving as the CEO and board chairman for EVIO, Waldrop obtained a Bachelor of Science degree from California State University-Long Beach and an MBA in finance from the University of Southern California. In 2014, he formed EVIO as a public company, and, in 2015, he oversaw the acquisition of EVIO’s first analytical laboratory. In past corporate incarnations, Waldrop served as board chairman and CEO of Newport Entertainment Group, president and COO of College Partnership, senior manager at AirTouch Cellular and vice president of operations for Leading Edge Broadband.
Also a driving force behind EVIO’s success, Glauser oversees strategic growth and day-to-day operations for the company. She additionally leads EVIO’s advisory services division. Glauser has a Bachelor of Science in mechanical engineering from the University of New Hampshire and an MBA from the University of Alabama. She is the founding chair of Women Grow-Las Vegas, has served on the FOCUS standards committee, is the coauthor of ‘Medical Marijuana Desk Reference’ and speaks frequently at cannabis industry conferences. Glauser has a 25-year background in engineering, management, consulting and startups, with expertise in business planning and operations, business process design, financial forecasting, risk, customer experience, and regulatory policy. She formerly served as a management consultant focusing on the energy industry, working with leading firms like Ernst & Young, IBM, Financial Times Group and SNL Financial.
In addition, guiding the EVIO team are chief science officer and Director Anthony Smith, Ph.D.; President Al Lustig, MBA; Evio Oregon Director and President Henry Grimmett, BS, MA; EVIO Labs Berkeley Laboratory Director Tobias Paquet, BS; EVIO Labs Colorado Laboratory Director Stephen Goldman, BS, MS; EVIO Labs Eugene Vice President of Sales Michael Lausmann; EVIO Labs California General Manager Catherine Emond, MS, MA; and EVIO Labs Eugene Vice President of Client Relations Sara Lausmann, BA.
For more information, visit the company’s website at www.EVIOLabs.com
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.